leisure time -WSS

leisure time

author：hotspot 2025-09-06 03:40:06 - browse：35

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

The drug, VX-548, blocks signals from pain-sensitive neurons before those electrical messages reach the brain. And in a pair of randomized trials, patients given a high dose of the oral medication after bunion surgery or abdominoplasty (a tummy tuck) reported less pain than those given a placebo. Those taking lower doses of the treatment showed no improvement compared to the placebo group, however.

While the pain reduction measured by these Phase 2 trials was statistically significant, it’s unclear how meaningful the drug’s benefits were to patients, with a commentary accompanying the study describing the treatment effect as “small.” But the study authors noted that participants on a high dose of VX-548 were less likely to prematurely stop their treatment because it wasn’t working than those on placebo or participants given a combination of two common painkillers, acetaminophen and hydrocodone.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Manchin plays down potential 3rd

WSS

15 die by electrocution after transformer explodes in northern India

Twill hunts for pharma partner to market its depression app

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

H5N1 bird flu found in pasteurized milk: what we know

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

More hospitals are billing patients as online messages surge

focus

leisure time

explore

Medical records are filled with copy

Dogs on Prozac: What pet anti

23andMe had bad news about my health. I wish a person had delivered it

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Hollywood unions extend contract negotiations for actors

Element Biosciences CEO lays out genome sequencing strategy

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA seeking to stop procedures at two unregulated stem cell clinics

Sports medicine is finally prioritizing gender equality

BridgeBio heart drug succeeds in pivotal study

explore

Diversity in clinical trials starts with building trust, experts say

Diversity in clinical trials starts with building trust, experts say

A look at other Americans who have crossed into North Korea over the years

What we know about the American soldier detained in North Korea

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

MultiPlan and major insurers sued for alleged medical price

focus

Wikipedia

focus

hotspot